Nisin S, a Novel Nisin Variant Produced by Ligilactobacillus salivarius P1CEA3
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076813 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ester Sevillano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facul…. Hauptthemen laut MEDLINE: Nisin, Ligilactobacillus salivarius, Bacteriocins. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MINISTERIO DE CIENCIA, INNOVACIÓN Y UNIVERSIDADES, ATRACCIÓN DE TALENTO PROGRAM of the Comunidad de Madrid, EMPLEO JUVENIL PROGRAM of the Comunidad de Madrid.
Abstract (Originalsprache)
Recently, the food industry and the animal farming field have been working on different strategies to reduce the use of antibiotics in animal production. The use of probiotic producers of antimicrobial peptides (bacteriocins) is considered to be a potential solution to control bacterial infections and to reduce the use of antibiotics in animal production. In this study, Ligilactobacillus salivarius P1CEA3, isolated from the gastrointestinal tract (GIT) of pigs, was selected for its antagonistic activity against Gram-positive pathogens of relevance in swine production. Whole genome sequencing (WGS) of L. salivarius P1ACE3 revealed the existence of two gene clusters involved in bacteriocin production, one with genes encoding the class II bacteriocins salivaricin B (SalB) and Abp118, and a second cluster encoding a putative nisin variant. Colony MALDI-TOF MS determinations and a targeted proteomics combined with massive peptide analysis (LC-MS/MS) of the antimicrobial peptides encoded by L. salivarius P1CEA3 confirmed the production of a 3347 Da novel nisin variant, termed nisin S, but not the production of the bacteriocins SalB and Abp118, in the supernatants of the producer strain. This is the first report of a nisin variant encoded and produced by L. salivarius, a bacterial species specially recognized for its safety and probiotic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Nutrición y Ciencia de los Alimentos (NUTRYCIAL), Sección Departamental de Nutrición y Ciencia de los Alimentos (SD-NUTRYCIAL), Facultad de Veterinaria, Universidad Complutense de Madrid (UCM), Avenida P…
ORCID-Profile: Luis M Cintas, Estefanía Muñoz-Atienza, Pablo E Hernández, Juan Borrero
Förderung
- MINISTERIO DE CIENCIA, INNOVACIÓN Y UNIVERSIDADES
- ATRACCIÓN DE TALENTO PROGRAM of the Comunidad de Madrid
- EMPLEO JUVENIL PROGRAM of the Comunidad de Madrid
- MINISTERIO DE CIENCIA E INNOVACIÓN
Zitieren
APA
Sevillano, E., Peña, N., Lafuente, I., Cintas, L. M., Muñoz-Atienza, E., Hernández, P. E., & Borrero, J. (2023). Nisin S, a Novel Nisin Variant Produced by Ligilactobacillus salivarius P1CEA3. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076813
Vancouver
Sevillano E, Peña N, Lafuente I, Cintas LM, Muñoz-Atienza E, Hernández PE, et al. Nisin S, a Novel Nisin Variant Produced by Ligilactobacillus salivarius P1CEA3. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076813
BibTeX
@article{Sevillano2023,
author = {Sevillano, Ester and Peña, Nuria and Lafuente, Irene and Cintas, Luis M and Muñoz-Atienza, Estefanía and Hernández, Pablo E and Borrero, Juan},
title = {Nisin S, a Novel Nisin Variant Produced by Ligilactobacillus salivarius P1CEA3},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076813}
}
EUVIMED